ABSTRACT
Clinical Application of Silics . . . . . . . . . . . . . . . . . 181
Influence on Intestinal Microflora . . . . . . . . . . . . 181
Direct Influence . . . . . . . . . . . . . . . . . . . . . . . . 181
Indirect Influence . . . . . . . . . . . . . . . . . . . . . . . 182
Interaction of HDS with Intestinal
Walls and Intestine Content . . . . . . . . . . . . . . . 183
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
A new enterosorbent silica has been developed and introduced into medicinal practice. This synthetic, a
highly disperse silica with an extended specific surface is characterized by its chemical purity, stability,
and physiological innocuousness. The regular structure of its surface as well as the presence of a large
number of surface reactive sites insure a high adsorptive capacity of Silics with respect to water, protein
molecules, toxins, pathogenic microorganisms and viruses. At present new technologies are being described
for application of Silics as an individual medicinal preparation of sorptive action and as an active basis for a
novel generation of composite drugs for multimodality therapy.
